Sutro Biopharma   Report issue

For profit Phase 1
Founded: South San Francisco CA United States (2003)

Organization Overview

First Clinical Trial
2018
NCT03424603
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sutro Biopharma | Sutro Biopharma, Inc.